The therapeutic armamentarium for Rheumatoid Arthritis is growing quickly and the treatments pose new potential toxicities. It is difficult for any clinician to stay abreast with the latest developments in DMARD drug safety and to be adequately equipped to assess new concerns raised in the literature. This Session aims to review recent developments in drug safety, to examine the methodology of such studies, and to discuss how clinicians manage such risks in their practice.
Upon completion of this session, participants should be able to:
- examine the drug safety literature with greater expertise
- prescribe DMARDs with a broader and deeper knowledge of potential toxicities
- discuss DMARD toxicities with their patients with greater comfort
- manage potential DMARD toxicities with greater skill
To see other sessions for this day, use the date buttons to the left.